VERA Vera Corp: Multiplikator forward rega marang pendapatan

Lambang korporat lan logo Vera Pharma (VERA)

Vera Therapeutics, Inc. (VERA) is a recognized innovator in nephrology with high institutional trust and the pricing power to dictate terms due to its unique treatment method for IgA nephropathy. The expected price-to-sales ratio reflects market expectations, with the metric currently standing at 189.30. Therapy development leverages artificial intelligence and synthesis automation, although final testing remains the responsibility of physicians.

Vera Therapeutics - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep VERA (periode 07.11.2026 - 17.11.2026)

Rincian metrik lan analitis perusahaan Vera Therapeutics (VERA)

- rega saiki lan proyeksi nilai saham:
Ringkesan analisis perusahaan:Vera Therapeutics (VERA)
Sampel barang veratx.com

The metric is calculated as the ratio of current market capitalization to expected future sales volume. This metric determines the market value of one dollar of revenue, reflecting the balance of supply and demand for the asset. For Vera Therapeutics, Inc. (VERA), this calculation is critical, as synergy with partners during atacicept testing directly impacts monetization rates. A decline in the projected P/S metric signals an increase in the investment discount.

Perusahaan pesaing

Multiplikator Forward P/S ARGX (argenx.com)|BioNTech Group (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ABIVAX - Multiplikator Forward P/S|ADMA - Multiplikator Forward P/S|Protagonist (PTGX) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Immunovant Inc|Rasio rega marang prakiraan pendapatan Kiniksa Pharmaceuticals|Grifols Group (GRFS) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Adaptive Biotechnologies Corp (ADPT)|Rasio rega marang prakiraan pendapatan CLDX (Celldex Therapeutics)|Rasio rega marang prakiraan pendapatan Aurinia Pharma AUPH|Rega forward marang dodolan BCRX|Dianthus Pharma - Multiplikator Forward P/S|PHVS - Multiplikator Forward P/S|ABCL: Multiplikator Forward P/S|TRML (Tourmaline Bio, Inc.) - Rasio rega marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan Intrexon|PHAR - Prakiraan rega marang pendapatan|Multiplikator Forward P/S NKTR|Rasio rega marang prakiraan pendapatan UPB (Upstream Bio Corp)|Rasio rega marang prakiraan pendapatan Zenas Biopharma, Inc. ZBIO|Rasio kapitalisasi marang dodolan sing dikarepake immunome.com (IMNM)|Gossamer Bio Inc - Multiplikator Forward P/S|Rega forward marang dodolan KALV (KalVista Pharmaceuticals, Inc.)|SEPN: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Pieris Pharmaceuticals Inc|Multiplikator forward rega marang pendapatan SVRA|Multiplikator forward rega marang pendapatan Rigel Pharmaceuticals (RIGL)|Multiplikator Forward P/S ANAB|ATXS - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan enGene Corp ENGN|Rasio kapitalisasi marang dodolan sing dikarepake RAPT Therapeutics, Inc. (RAPT)|Aerovate - Multiplikator Forward P/S|ACRS - Multiplikator Forward P/S|KYTX (Kyverna Therapeutics) - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Tiziana Life Sciences Ltd. (TLSA)|Multiplikator forward rega marang pendapatan CABA|Ventyx Biosciences (VTYX) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S THTX|AVTX (Avalo Therapeutics, Inc) - Rega forward marang dodolan|Multiplikator Forward P/S ELDN (eledon.com)|AGEN - Multiplikator forward rega marang pendapatan|CLYM - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan ZURA|ATYR: Multiplikator Forward P/S|Adagene Corp (ADAG) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan IMA|Shattuck Labs, Inc. - Rega mangsa ngarep marang pendapatan|Rasio rega marang prakiraan pendapatan Equillium Inc (EQ)|Multiplikator Forward P/S Connect Biopharma Holdings (CNTB)|Rasio rega marang prakiraan pendapatan Immunic, Inc. IMUX|Multiplikator Forward P/S Atara Biotherapeutics ATRA|IFRX - Rasio rega marang prakiraan pendapatan|XFOR: Rasio rega marang prakiraan pendapatan|ACET: Multiplikator Forward P/S|CELU - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan inmunebio.com|Kapitalisasi marang prakiraan pendapatan BRNS (barinthusbio.com)|Multiplikator Forward P/S KZR|Multiplikator Forward P/S SAB Biotherapeutics, Inc (SABS)|Multiplikator Forward P/S AKTX (Akari Therapeutics, Plc)|Multiplikator Forward P/S enlivex.com ENLV|QTTB: Multiplikator forward rega marang pendapatan|GOVX - Multiplikator Forward P/S|Edesa Biotech Inc (EDSA) - Rasio rega marang prakiraan pendapatan|IBIO - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan carismatx.com|XTLB: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Bolt Biotherapeutics Inc. (BOLT)|HCW Biologics - Kapitalisasi marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan aptevotherapeutics.com APVO|AIM - Multiplikator forward rega marang pendapatan|Aditxt - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake GRI Bio Corporation GRI|xortx.com (XRTX) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep reshapelifesciences.com (HIND)|Rasio rega marang prakiraan pendapatan Revelation Bio|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Indaptus Therapeutics, Inc. INDP|Rasio rega marang prakiraan pendapatan BiondVax Pharmaceuticals (SCNI)|Multiplikator forward rega marang pendapatan CalciMedica CALI|Rasio rega marang prakiraan pendapatan Affimed AFMD|ALLK - Multiplikator forward rega marang pendapatan|HOOKIPA Pharma, Inc. - Multiplikator Forward P/S|Rega forward marang dodolan IGMS (igmbio.com)|ITOS (iTeos Therapeutics, Inc.) - Multiplikator forward rega marang pendapatan|Ocean Biomedical Corp (OCEA) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan TC BioPharm (Holdings) PLC|Multiplikator Forward P/S thirdharmonicbio.com